Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 967987, 7 pages
http://dx.doi.org/10.1155/2013/967987
Clinical Study

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid

1Department of Dermatology and Venereology, Medical University of Lodz, 5 Krzemieniecka Street, 94-017 Lodz, Poland
2Laboratory of Nephropathology of Medical University of Lodz, 251 Pomorska Street, 92-213 Lodz, Poland

Received 4 March 2013; Accepted 25 June 2013

Academic Editor: Alex Kleinjan

Copyright © 2013 Agnieszka Zebrowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • T. Schmidt, C. Sitaru, K. Amber, and M. Hertl, “BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?,” British Journal of Dermatology, 2014. View at Publisher · View at Google Scholar
  • Sébastien Le Jan, Julie Plée, David Vallerand, Aurélie Dupont, Elodie Delanez, Anne Durlach, Patricia L Jackson, J Edwin Blalock, Philippe Bernard, and Frank Antonicelli, “Innate Immune Cell–Produced IL-17 Sustains Inflammation in Bullous Pemphigoid,” Journal of Investigative Dermatology, 2014. View at Publisher · View at Google Scholar
  • Julie Plee, Sebastien Le Jan, Jerome Giustiniani, Coralie Barbe, Pascal Joly, Christophe Bedane, Pierre Vabres, Francois Truchetet, Francois Aubin, Frank Antonicelli, and Philippe Bernard, “Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Masutaka Furue, and Takafumi Kadono, “Bullous pemphigoid: What's ahead?,” The Journal of Dermatology, 2015. View at Publisher · View at Google Scholar
  • Derya Uçmak, Zeynep Meltem Akkurt, Hatice Yüksel, and Mustafa Arica, “Analysis of serum cytokine levels in patients with pemphigus vulgaris,” Turkderm Deri Hastaliklari ve Frengi Arsivi, vol. 49, no. 1, pp. 25–30, 2015. View at Publisher · View at Google Scholar
  • Agnieszka Wasilewska, Marta Winiarska, Małgorzata Olszewska, and Lidia Rudnicka, “Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases,” Postepy Dermatologii i Alergologii, vol. 33, no. 4, pp. 247–252, 2016. View at Publisher · View at Google Scholar
  • Jane Li, Rangsima Reantragoon, Lyudmila Kostenko, Alexandra Jane Corbett, George Varigos, and Francis Robert Carbone, “The frequency of mucosal-associated invariant T cells is selectively increased in dermatitis herpetiformis,” Australasian Journal of Dermatology, 2016. View at Publisher · View at Google Scholar
  • Michael C. Kwa, and Jonathan I. Silverberg, “Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data,” American Journal of Clinical Dermatology, 2017. View at Publisher · View at Google Scholar
  • Yale Liu, Liang Li, and Yumin Xia, “BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • K. Juczynska, A. Wozniacka, E. Waszczykowska, M. Danilewicz, M. Wagrowska-Danilewicz, J. Wieczfinska, R. Pawliczak, and A. Zebrowska, “Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis,” Mediators of Inflammation, vol. 2017, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • Agnieszka Żebrowska, Anna Woźniacka, Katarzyna Juczyńska, Kamila Ociepa, Elżbieta Waszczykowska, Izabela Szymczak, and Rafał Pawliczak, “Correlation between IL-36α and IL-17 and Activity of the Disease in Selected Autoimmune Blistering Diseases,” Mediators of Inflammation, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Fereshteh Alsahebfosoul, Hamidreza Jahanbani-Ardakani, Reza Ghavimi, Nahid Sedaghat, and Masoud Etemadifar, “Serum level of interleukin 36 in patients with multiple sclerosis,” Journal of Immunoassay and Immunochemistry, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Lenche Chakievska, Maike M. Holtsche, Axel Künstner, Stephanie Goletz, Britt-Sabina Petersen, Diamant Thaci, Saleh M. Ibrahim, Ralf J. Ludwig, Andre Franke, Christian D. Sadik, Detlef Zillikens, Christoph Hölscher, Hauke Busch, and Enno Schmidt, “IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid,” Journal of Autoimmunity, 2018. View at Publisher · View at Google Scholar
  • Frank Antonicelli, Sébastien Le Jan, Julie Plée, and Philippe Bernard, “Inflammation in Bullous Pemphigoid, a Skin Autoimmune Disease,” Immunity and Inflammation in Health and Disease, pp. 213–222, 2018. View at Publisher · View at Google Scholar